Great West Life Assurance CO Intellia Therapeutics, Inc. Transaction History

Great West Life Assurance CO

$58 Billion
Q4 2024

A detailed history of Great West Life Assurance CO transactions in Intellia Therapeutics, Inc. stock. As of the latest transaction made, Great West Life Assurance CO holds 25,546 shares of NTLA stock, worth $277,429. This represents 0.0% of its overall portfolio holdings.

Number of Shares

25,546

Previous 25,464 0.32%

Holding current value

$277,429

Previous $524,000 43.13%

% of portfolio

0.0%

Previous 0.0%

23 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 13, 2025	BUY	$11.41 - $21.09 $935 - $1,729	82 Added 0.32%	25,546 $298,000
Q3 2024 Nov 13, 2024	SELL	$19.72 - $27.36 $10,195 - $14,145	-517 Reduced 1.99%	25,464 $524,000
Q2 2024 Aug 12, 2024	SELL	$20.02 - $27.22 $32,632 - $44,368	-1,630 Reduced 5.9%	25,981 $582,000
Q1 2024 May 13, 2024	BUY	$23.82 - $32.8 $7,860 - $10,823	330 Added 1.21%	27,611 $759,000
Q4 2023 Feb 13, 2024	BUY	$23.16 - $32.34 $84,117 - $117,458	3,632 Added 15.36%	27,281 $826,000
Q3 2023 Nov 14, 2023	BUY	$31.62 - $45.78 $176,819 - $256,001	5,592 Added 30.97%	23,649 $747,000
Q2 2023 Aug 10, 2023	SELL	$34.58 - $46.03 $39,767 - $52,934	-1,150 Reduced 5.99%	18,057 $741,000
Q1 2023 May 12, 2023	BUY	$33.3 - $44.82 $116,483 - $156,780	3,498 Added 22.27%	19,207 $717,000
Q4 2022 Feb 10, 2023	BUY	$33.21 - $62.69 $204,374 - $385,794	6,154 Added 64.41%	15,709 $551,000
Q3 2022 Nov 01, 2022	BUY	$53.92 - $71.7 $515,205 - $685,093	9,555 New	9,555 $534,000
Q2 2022 Aug 09, 2022	BUY	$38.49 - $76.21 $1,385 - $2,743	36 Added 1.05%	3,453 $178,000
Q1 2022 May 12, 2022	SELL	$58.27 - $118.99 $2,097 - $4,283	-36 Reduced 1.04%	3,417 $264,000
Q4 2021 Feb 14, 2022	BUY	$100.76 - $138.36 $3,325 - $4,565	33 Added 0.96%	3,453 $407,000
Q2 2021 Aug 11, 2021	BUY	$60.88 - $161.91 $32,449 - $86,298	533 Added 18.46%	3,420 $553,000
Q1 2021 May 17, 2021	SELL	$46.59 - $83.68 $24,413 - $43,848	-524 Reduced 15.36%	2,887 $230,000
Q4 2020 Feb 16, 2021	BUY	$18.83 - $63.53 $19,263 - $64,991	1,023 Added 42.84%	3,411 $185,000
Q4 2019 Feb 11, 2020	BUY	$10.43 - $17.67 $24,906 - $42,195	2,388 New	2,388 $35,000
Q3 2019 Oct 25, 2019	SELL	$13.07 - $18.51 $58,815 - $83,295	-4,500 Closed	0 $0
Q4 2018 Feb 12, 2019	SELL	$11.39 - $27.13 $462,547 - $1.1 Million	-40,610 Reduced 90.02%	4,500 $59,000
Q3 2018 Nov 13, 2018	SELL	$25.78 - $32.6 $1.34 Million - $1.69 Million	-51,921 Reduced 53.51%	45,110 $1.3 Million
Q2 2018 Aug 10, 2018	BUY	$20.02 - $30.79 $47,947 - $73,742	2,395 Added 2.53%	97,031 $2.65 Million
Q1 2018 May 10, 2018	BUY	$19.43 - $34.95 $1.81 Million - $3.26 Million	93,236 Added 6659.71%	94,636 $2 Million
Q3 2017 Nov 09, 2017	BUY	$15.16 - $25.75 $21,224 - $36,050	1,400	1,400 $34,000

Others Institutions Holding NTLA

# of Institutions

336

Shares Held

96.1M

Call Options Held

1.06M

Put Options Held

863K

View Full List

About Intellia Therapeutics, Inc.

Ticker NTLA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 76,011,800
Market Cap $825M
Description
Intellia Therapeutics, Inc., a genome editing company, focuses on the development of therapeutics. The company's in vivo programs include NTLA-2001, which is in Phase 1 clinical trial for the treatment of transthyretin amyloidosis; and NTLA-2002 for the treatment of hereditary angioedema, as well as other liver-focused programs comprising hemoph...

More about NTLA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Great West Life Assurance CO , based on Form 13F filings with the SEC.

News

Stay updated on Great West Life Assurance CO with notifications on news.

Account

Great West Life Assurance CO Intellia Therapeutics, Inc. Transaction History